Isoform-specific protein kinase C activity at variable Ca2+ entry during coronary artery contraction by vasoactive eicosanoids

Canadian Journal of Physiology and Pharmacology

Volumn 76, Issue 12, 1998, Pages 1110-1119

  Kanashiro, Celia A ^a   Khalil, Raouf A ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium influx; Contraction; Eicosanoids; Isoform; Protein kinase C; Vascular smooth muscle

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CALCIUM; CALCIUM CHANNEL; ENZYME ANTIBODY; ICOSANOID; PROSTAGLANDIN F2 ALPHA; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY SPASM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; IMMUNOBLOTTING; MALE; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; SWINE; VASCULAR SMOOTH MUSCLE;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; CALCIUM CHANNELS; CALCIUM SIGNALING; CORONARY VESSELS; DINOPROST; EICOSANOIDS; MALE; MUSCLE, SMOOTH, VASCULAR; PROTEIN KINASE C; SWINE; VASOCONSTRICTION;

EID: 0032459578     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/cjpp-76-12-1110     Document Type: Article

References (41)

1. Andrea, J.E., and Walsh, M.P. 1992. Protein kinase C of smooth muscle. Hypertension (Dallas), 20: 585-595.
2. Cannon, P.J. 1984. Eicosanoids and the blood vessel wall. Circulation, 70: 523-528.
3. Clément-Chomienne, O., and Walsh, M.P. 1996. Identification of protein kinase C isozymes in smooth muscle: partial purification and characterization of chicken gizzard PKCζ. Biochem. Cell Biol. 74: 51-65.
4. Cushing, D.J., Makujina, S.R., Sabouni, M.H., and Mustafa, S.J. 1991. Protein kinase C and phospholipase C in adenosine receptor- mediated relaxation in coronary artery. Am. J. Physiol. 261: H1848-H1854.
5. DeFeo, T.T., and Morgan, K.G. 1985. Calcium-force relationships as detected with aequorin in two different vascular smooth muscles of the ferret. J. Physiol. (London), 369: 269-282.
6. 2+ release during drug induced activation of the rabbit aorta. Pfluegers Arch. 348: 13-22.
7. Fukumoto, S., Nishizawa, Y., Hosoi, M., Koyama, H., Yamakawa, K., Ohno, S., and Morii, H. 1997. Protein kinase C delta inhibits the proliferation of vascular smooth muscle cells by suppressing G1 cyclin expression. J. Biol. Chem. 272: 13816-13822.
8. Fukuo, K., Morimoto, S., Koh, E., Yukawa, S., Tsuchiya, H., Imanaka, S., Yamamoto, H., Onishi, T., and Kumahara, Y. 1986. Effects of prostaglandins on the cytosolic free calcium concentration in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 136: 247-252.
9. Haller, H., Baur, E., Quass, P., Behrend, M., Lindschau, C., Distler, A., and Luft, F.C. 1995. High glucose concentrations and protein kinase C isoforms in vascular smooth muscle cells. Kidney Int. 47: 1057-1067.
10. Hartshorne, D.J. 1987. Physiology of the gastrointestinal tract. 2nd ed. Edited by I.R. Johnson. Raven Press, New York. pp. 423-482.
11. Hempel, A., Maasch, C., Heintze, U., Lindschau, C., Dietz, R., Luft, F.C., and Haller, H. 1997. High glucose concentrations increase endothelial cell permeability via activation of protein kinase Cα. Circ. Res. 81: 363-371.
12. 2+ signaling and a new class of inhibitors. Methods Enzymol. 139: 570-582.
13. Himpens, B., Matthijs, G., Somlyo, A.V., Butler, T.M., and Somlyo, A.P. 1988. Cytoplasmic free calcium, myosin light chain phosphorylation, and force in phasic and tonic smooth muscle. J. Gen. Physiol. 92: 713-729.
14. 2+-independent contraction in vascular smooth muscle. Am. J. Physiol. 271: C589-C594.
15. 2+-sensitization of smooth muscle. Biophys. J. 72: A179.
16. Jiang, M.J., and Morgan, K.G. 1987. Intracellular calcium levels in phorbol ester-induced contractions of vascular muscle. Am. J. Physiol. 253: H1365-H1371.
17. Kageyama, M., Mori, T., Yanagisawa, T., and Taira, N. 1991. Is staurosporine a specific inhibitor of protein kinase C in intact porcine coronary arteries? J. Pharmacol. Exp. Ther. 259: 1019-1026.
18. Kamm, K.E., and Stull, J.T. 1989. The function of myosin light chain kinase phosphorylation in smooth muscle. Annu. Rev. Pharmacol. Toxicol. 25: 593-620.
19. Kanashiro, C.A., and Khalil, R.A. 1998. Signal transduction by protein kinase in mammalian cells. J. Clin. Exp. Pharmacol. 25: 974-985.
20. 2 in the rabbit coronary artery. Circ. Res. 60: 402-409.
21. Khalil, R.A., and van Breemen, C. 1988. Sustained contraction of vascular smooth muscle: calcium influx or C-kinase activation? J. Pharmacol. Exp. Ther. 244: 537-542.
22. +. Pfluegers Arch. 416: 727-734.
23. 2+-independent isoforms of protein kinase C differentially translocate in smooth muscle. Am. J. Physiol. 263: C714-C719.
24. 4-induced coronary vasoconstriction by leukotriene antagonists in the anesthetized dog. J. Pharmacol. Exp. Ther. 241: 174-180.
25. 2+, phospholipid-dependent protein kinase associated with plasma membrane. Nature (London), 301: 621-623.
26. 2+-free media are mediated by different signal transduction pathways in rat aorta. Br. J. Pharmacol. 110: 875-881.
27. 2+-requiring proteinase. Proc. Natl. Acad. Sci. U.S.A. 82: 6435-6439.
28. Miller, J.R., Hawkins, D.J., and Wells, J.N. 1986. Phorbol diesters alter the contractile responses of coronary artery. J. Pharmacol. Exp. Ther. 239: 38-42.
29. 2 on coronary flow and myocardial function. Am. J. Physiol. 255: H153-H159.
30. Mischak, H., Goodnight, J., Kolch, W., Martiny-Baron, G., Schächtele, C., Kazanietz, M.G., Blumberg, P.M., Pierce, J.H., and Mushinski, J.F. 1993. Overexpression of protein kinase C-δ and -ε in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J. Biol. Chem. 268: 6090-6096.
31. Niedel, J.E., Kuhn, L.J., and Vandenbark, G.R. 1983. Phorbol diester receptor copurifies with protein kinase C. Proc. Natl. Acad. Sci. U.S.A. 80: 36-40.
32. Nishida, M., Kuzuya, T., Hoshida, S., Kim, Y., Kitabatake, A., Kamada, T., and Tada, M. 1990. Polymorphonuclear leukocytes induced vasoconstriction in isolated canine coronary arteries. Circ. Res. 66: 253-258.
33. 2+ sensitivity in norepinephrine-activated vascular smooth muscle. Am. J. Physiol. 259: H2-H8.
34. Nishizuka, Y. 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science (Washington, D.C.), 258: 607-614.
35. Pollock, W.K., Armstrong, R.A., Brydon, L.J., Jones, R.L., and MacIntyre, D.E. 1984. Thromboxane-induced phosphatidate formation in human platelets. Relation to receptor occupancy and to changes in cytosolic free calcium. Biochem. J. 219: 833-842.
36. 2+] sensitivity of myosin phosphorylation in intact swine arterial smooth muscle. J. Physiol. (London), 429: 77-94.
37. Sasaguri, T., Itoh, T., Hirata, M., Kitamura, K., and Kuriyama, H. 1987. Regulation of coronary artery tone in relation to the activation of signal transductors that regulate calcium homeostasis. J. Am. Coll. Cardiol. 9: 1167-1175.
38. Schaap, D., Parker, P.J., Bristol, A., Kriz, R., and Knopf, J. 1989. Unique substrate specificity and regulatory properties of PKC-epsilon: a rationale for diversity. FEBS Lett. 243: 351-357.
39. Singer, H.A., and Baker, K.M. 1987. Calcium dependence of phorbol 12,13-dibutyrate-induced force and myosin light chain phosphorylation in arterial smooth muscle. J. Pharmacol. Exp. Ther. 243: 814-821.
40. Togashi, H., Hirshman, C.A., and Emala, C.W. 1997. Qualitative immunoblot analysis of PKC isoforms expressed in airway smooth muscle. Am. J. Physiol. 272: L603-L607.
41. van Breemen, C., Aaronson, P.I., Cauvin, C.A., Loutzenheiser, A.W., Mangel, A.W., and Saida, K. 1982. The calcium cycle in arterial smooth muscle. In Calcium blockers: mechanisms of action and clinical applications. Edited by S.F. Flaim and R. Zelis. Urban and Schwarzenberg, Baltimore, Md. pp. 53-63.